Meningococcal ACWY Vaccine

(MenACWY/Quadrivalent Meningococcal Vaccine)

Protects against:

• Meningococcal Disease (Serogroups A, C, W, Y): Bacterial meningitis (brain/spinal cord infection), septicemia (blood infection), limb amputation, hearing loss, brain damage, organ failure, death (can kill within 24 hours)

Who should get it:

Pediatric (Children & Adolescents):

• All adolescents 11-12 years (routine dose)
• Booster at age 16 years
• Children 2 months and older in high-risk situations:
  • Asplenia (no spleen) or complement deficiency
  • HIV infection
  • Living in or traveling to high-risk areas
  • College/university students living in dormitories
  • Military recruits
  • Outbreak exposure

Adults:

• Adults not previously vaccinated, especially:
  • College students living in residence halls
  • Military recruits and personnel
  • Microbiologists working with meningococcal bacteria
  • People with asplenia or complement deficiencies
  • People with HIV infection
  • Adults in outbreak settings
  • Those in close contact with infected individuals
• Booster every 5 years for those with continued risk

Travelers:

• Required for specific destinations:
  • Hajj/Umrah pilgrims to Saudi Arabia (mandatory – visa requirement)
  • Travel to the “Meningitis Belt” in sub-Saharan Africa (Senegal to Ethiopia)
• Recommended for:
  • Extended stays in high-risk regions
  • Travelers during dry season in Africa (December-June)
  • Healthcare workers in endemic areas
  • Humanitarian workers and volunteers
  • Adventure travelers in close contact with local populations

Schedule:

Children & Adolescents:

Routine vaccination:

• Primary dose: 11-12 years
• Booster dose: 16 years

High-risk children (starting at 2 months):

• 2-dose primary series (timing depends on age and vaccine brand)
• Boosters every 5 years if risk continues

Adults:

Previously unvaccinated:

• Single dose
• Booster every 5 years if at continued risk

Previously vaccinated in adolescence:

• Booster if continuing risk (college, military, travel)

Travelers:

• At least 2 weeks before travel (preferably 4 weeks)
• Hajj requirement: Certificate valid 3-5 years depending on vaccine type
• Booster recommended every 5 years for repeated travel to endemic areas

Why vaccinate:

For Children & Adolescents:

• Meningococcal disease strikes quickly – can be fatal within hours
• Adolescents have second-highest risk after infants
• 10-15% of survivors suffer permanent disabilities – amputation, deafness, brain damage
• College dormitories are high-risk environments
• Protects during social activities with close contact
• School outbreaks can spread rapidly
• Vaccination prevents devastating complications in otherwise healthy teens
• Safe and highly effective (85-90% protection)

For Adults:

• Rapid progression – healthy person to critical condition in 24-48 hours
• Close-living situations (dorms, barracks) increase transmission risk
• Occupational protection for healthcare and laboratory workers
• Prevents outbreaks in congregate settings
• High-risk adults (immunocompromised) face severe complications
• Peace of mind for those in high-risk professions
• Protects family and close contacts from exposure

For Travelers:

• Mandatory for Hajj/Umrah – no exceptions, entry denied without certificate
• Meningitis Belt has highest disease rates globally
• Outbreaks common during dry season (attack rates 100-800 per 100,000)
• Disease strikes tourists – multiple cases documented annually
• Limited healthcare access in remote endemic regions
• Prevents medical evacuation and hospitalization abroad
• Protects against vaccine-preventable tragedy
• Some strains (W, A) particularly common in Africa
• Mass gatherings (Hajj) create perfect transmission conditions
• Certificate of vaccination required at Saudi border control

Universal Benefits:

• Prevents a devastating, life-threatening disease
• Long-lasting protection (5+ years)
• Well-tolerated with minimal side effects
• Protects vulnerable populations through community immunity
• Peace of mind in high-risk situations
• No treatment can reverse damage once it begins – prevention is critical

Important note:

Meningococcal disease is a medical emergency – it can kill within 24 hours of first symptoms. Early vaccination is critical as the disease progresses extremely rapidly. Adolescents need a booster at 16 because immunity wanes and this age group remains at elevated risk. Hajj/Umrah pilgrims must present valid vaccination certificates – vaccinate at least 10 days before travel (ideally 2-4 weeks). The vaccine does not protect against serogroup B – a separate vaccine exists for that strain. Boosters are needed every 5 years for those with ongoing risk. Don’t delay – this vaccine can prevent a devastating, fast-moving disease with no cure.